Platinum-based therapy is the standard of care in patients who have HER2-negative, advanced esophagogastric cancer (AEGC).
Randomized, Phase II Study Prospectively Evaluating Treatment of Metastatic Esophageal, Gastric, or Gastroesophageal Cancer by Gene Expression of ERCC1: SWOG S1201